EX-FILING FEES 5 ex_374823.htm EXHIBIT FILING FEES ex_374823.htm

Exhibit 107

 

Calculation of Filing Fee Table

 

           S-8          

(Form Type)

 

                NovaBay Pharmaceuticals, Inc.               

(Exact Name of Registrant as Specified in its Charter)

 

 

Table 1: Newly Registered Securities

 

Security

Type

Security

Class Title(1)

Fee

Calculation

or Carry

Forward Rule

Amount

Registered(1)

Proposed

Maximum

Offering

Price Per

Share

Maximum

Aggregate

Offering

Price(2)

Fee Rate

Amount of

Registration

Fee

Equity

Common Stock, par value $0.01 per share

457(c), (h)

1,910,634

$0.20

$382,126.80

0.0000927

$35.42

Total Offering Amounts:

$382,126.80

  

$35.42

Total Fees Previously Paid:

—

Total Fee Offsets:

— 

Net Fee Due:

$35.42

 

(1)

This represents an automatic increase in the number of shares of common stock of the registrant reserved for issuance under the NovaBay Pharmaceuticals, Inc. 2017 Omnibus Incentive Plan, pursuant to an evergreen provision contained in Section 4(a) therein. Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers any additional securities that may from time to time be offered or issued resulting from any stock splits, stock dividends, recapitalizations or other similar transactions.

 

(2)

This calculation is made solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and (h) under the Securities Act, based on the average of the high and low sales prices of the registrant’s common stock on May 10, 2022, as reported by NYSE American LLC.